David S Burgess

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Pharmacotherapy

Microbiology spectrum

Journal of clinical pharmacology

University of Kentucky College of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kentucky College of Pharmacy Sep 01 2012

United States

Chair and Professor :: Department of Pharmacy Practice and Science

Publications

Hope H Brandon, David S Burgess, Katie L Wallace, Elizabeth J Beckman, Katherine Olney
Vancomycin AUC 0-24 estimation using first-order pharmacokinetic methods in pediatric patients. Pharmacotherapy 44 (4) (2024)
Justin A Clark, David S Burgess
Comparing the activity of broad-spectrum beta-lactams in combination with aminoglycosides against VIM-producing Enterobacteriaceae . Microbiology spectrum (2024)
Hope H Brandon, David S Burgess, Katie L Wallace, Elizabeth J Beckman, Katherine Olney
Vancomycin AUC 0-24 estimation using first-order pharmacokinetic methods in pediatric patients. Pharmacotherapy (2024)
Hope H Brandon, David S Burgess, Katie L Wallace, Elizabeth J Beckman, Katherine Olney
Vancomycin AUC 0-24 estimation using first-order pharmacokinetic methods in pediatric patients. Pharmacotherapy 44 (4) (2024)
Katherine Olney, Manjunath Amit P Pai, Jenni K Thomas, Donna R Burgess, William J Olney, Rebecca A Bruning, Kamron A Griffith, Danielle V Casaus, Elizabeth Crance, James Z Porterfield, David S Burgess
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy (2024)
Katherine Olney, Manjunath Amit P Pai, Jenni K Thomas, Donna R Burgess, William J Olney, Rebecca A Bruning, Kamron A Griffith, Danielle V Casaus, Elizabeth Crance, James Z Porterfield, David S Burgess
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy 44 (8) (2024)
Katherine Olney, Katie L Wallace, Ryan P Mynatt, David S Burgess, Kaitlyn Grieves, Austin Willett, Johann Mani, Alexander H Flannery
Comparison of Bayesian-derived and first-order analytic equations for calculation of vancomycin area under the curve. Pharmacotherapy 42 (4) (2022)
Katherine Olney, Justin A Clark, David S Burgess
Time Above All Else: Pharmacodynamic Analysis of β-Lactams in Critically Ill Patients. Journal of clinical pharmacology (2021)
Alexander H Flannery, Natalie L Delozier, Samuel A Effoe, Katie L Wallace, Aaron M Cook, David S Burgess
First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients. Pharmacotherapy 40 (12) (2020)

David S Burgess.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David S Burgess